MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, BBOT has $448,381K in assets. $37,285K in debts. $373,687K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1233.97%
Quick Ratio
1233.97%
Cash Ratio
1066.43%
Debt to Asset Ratio
8.32%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Other non-current assets
    • Prepaid expense and other curren...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued research and development...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
373,687
Short-term marketable securities
51,773
Receivables from related parties
386
Prepaid expense and other current assets
6,550
Total current assets
432,396
Property and equipment, net
956
Operating lease right-of-use asset
2,330
Other non-current assets
12,567
Restricted cash
132
Total assets
448,381
Accounts payable
1,374
Accrued compensation and benefits
5,746
Accrued research and development liabilities
25,951
Accrued professional services
674
Payables to related parties
534
Operating lease liability, current
522
Other accrued liabilities
240
Participation right liability
0
Total current liabilities
35,041
Operating lease liability, noncurrent
2,244
Total liabilities
37,285
Preference stock, value-Redeemable Convertible Preferred Stock
0
Preference stock, value-Preferred Stock
0
Common stock, 0.0001 par value 500,000,000 and 41,341,250 shares authorized as of december 31, 2025 and december 31, 2024, respectively 79,991,768 and 28,415 shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively
8
Additional paid-in capital
767,639
Accumulated deficit
-356,567
Accumulated other comprehensive income
16
Total stockholders' equity (deficit)
411,096
Total liabilities, redeemable convertible preferred stock, and stockholders' equity (deficit)
448,381
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$373,687K Short-term marketablesecurities$51,773K Prepaid expense andother current assets$6,550K Receivables from relatedparties$386K Total current assets$432,396K Other non-currentassets$12,567K Operating leaseright-of-use asset$2,330K Property and equipment,net$956K Restricted cash$132K Total assets$448,381K Total liabilities,redeemable convertible...$448,381K Total stockholders'equity (deficit)$411,096K Total liabilities$37,285K Accumulated deficit-$356,567K Additional paid-in capital$767,639K Total currentliabilities$35,041K Operating leaseliability, noncurrent$2,244K Accumulated othercomprehensive income$16K Common stock, 0.0001par value...$8K Accrued research anddevelopment liabilities$25,951K Accrued compensationand benefits$5,746K Accounts payable$1,374K Accrued professionalservices$674K Payables to relatedparties$534K Operating leaseliability, current$522K Other accruedliabilities$240K

BridgeBio Oncology Therapeutics, Inc. (BBOT)

BridgeBio Oncology Therapeutics, Inc. (BBOT)